We are live on ! Find out more
ARNA

Arena Pharmaceuticals Inc
ARNA

Delisted

ARNA was delisted on the 10th of March, 2022.

Back to rankings

129 hedge funds and large institutions have $628M invested in Arena Pharmaceuticals Inc in 2014 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 33 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

3% less capital invested

Capital invested by funds: $645M → $628M (-$16.9M)

10% less first-time investments, than exits

New positions opened: 19 | Existing positions closed: 21

2% less funds holding

Funds holding: 131 → 129 (-2)

25% less repeat investments, than reductions

Existing positions increased: 33 | Existing positions reduced: 44

47% less call options, than puts

Call options by funds: $22.8M | Put options by funds: $43.1M

Holders
129
Holders Change
-2
Holders Change %
-1.53%
% of All Funds
3.71%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
19
Increased
33
Reduced
44
Closed
21
Calls
$22.8M
Puts
$43.1M
Net Calls
-$20.2M
Net Calls Change
+$4.67M

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$19.9M
2
Norges Bank
Norges Bank
Norway
+$13.7M
3
Morgan Stanley
Morgan Stanley
New York
+$8.89M
4
Group One Trading
Group One Trading
Illinois
+$4.34M
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$2.6M

Top Sellers

Rank Fund Capital Flow
1
BA
BlackRock Advisors
Delaware
-$6.18M
2
BFA
BlackRock Fund Advisors
California
-$4.12M
3
Goldman Sachs
Goldman Sachs
New York
-$3.68M
4
State Street
State Street
Massachusetts
-$3.57M
5
Bank of America
Bank of America
North Carolina
-$3.21M
Name Holding Trade Value Shares
Change 		Change in
Stake
MCM
76
Murphy Capital Management
New Jersey
$263K – – –
Creative Planning
77
Creative Planning
Kansas
$248K +$71.2K +1,130 +36%
Barclays
78
Barclays
United Kingdom
$245K +$235K +3,736 +325%
CCMH
79
Cornerstone Capital Management Holdings
New York
$230K +$630 +10 +0.3%
Jane Street
80
Jane Street
New York
$203K +$218K +3,464 New
U
81
UBS
Switzerland
$195K -$33.4K -530 -14%
HSBC Holdings
82
HSBC Holdings
United Kingdom
$189K – – –
GCP
83
GSA Capital Partners
United Kingdom
$186K +$200K +3,175 New
VKH
84
Virtu KCG Holdings
New York
$169K +$79.3K +1,259 +78%
SI
85
SII Investments
Wisconsin
$146K -$28.6K -455 -16%
TAM
86
Telluride Asset Management
Minnesota
$142K +$153K +2,430 New
AB
87
Amalgamated Bank
New York
$126K +$8.56K +136 +7%
KBC Group
88
KBC Group
Belgium
$124K +$16.6K +264 +14%
Commonwealth Equity Services
89
Commonwealth Equity Services
Massachusetts
$121K -$1.26K -20 -1%
AIP
90
Ameritas Investment Partners
Nebraska
$115K +$5.67K +90 +5%
Canada Life
91
Canada Life
Manitoba, Canada
$113K +$58.1K +922 +90%
HCM
92
Hollencrest Capital Management
California
$110K – – –
N
93
Nuveen
North Carolina
$104K -$2.71K -43 -2%
PAM
94
Princeton Alpha Management
New Jersey
$103K +$110K +1,754 New
GHF
95
Good Harbor Financial
Illinois
$97K – – –
SG Americas Securities
96
SG Americas Securities
New York
$91K +$97.9K +1,555 New
PNC Financial Services Group
97
PNC Financial Services Group
Pennsylvania
$86K – – –
NFG
98
Next Financial Group
Texas
$86K +$124K +1,970 New
Citigroup
99
Citigroup
New York
$65K -$299K -4,754 -81%
Fisher Asset Management
100
Fisher Asset Management
Washington
$64K – – –
2 3
4
5 6

ARNA Hedge Fund Activity: Q2 2014 in Review

129 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Arena Pharmaceuticals Inc (ARNA) for Q2 2014, worth a combined $628M — down 2.6% from $645M a quarter earlier.

Sellers outnumbered buyers: 21 funds closed out of ARNA and 19 opened new positions — a net loss of 2 holders — while 44 trimmed existing stakes and 33 added.

The largest buyer was Deerfield Management, adding an estimated $19.9M. The largest seller was BlackRock Advisors, cutting an estimated $6.18M.

  • 129 institutional investors held Arena Pharmaceuticals Inc (ARNA) as of Q2 2014, down from 131 in Q1 2014.
  • Funds reported $628M of Arena Pharmaceuticals Inc stock for Q2 2014, down 2.6% quarter-over-quarter.
  • 19 funds opened new Arena Pharmaceuticals Inc positions in Q2 2014 and 21 closed out, a net change of -2 holders.
  • The largest Arena Pharmaceuticals Inc buyer in Q2 2014 was Deerfield Management, an estimated $19.9M added.
  • The largest Arena Pharmaceuticals Inc seller in Q2 2014 was BlackRock Advisors, an estimated $6.18M sold.

Based on aggregated 13F filings for Q2 2014.